Clinicopathological features of microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) in Japanese patients.

被引：0
|
作者：
Kawazoe, Akihito
Shitara, Kohei
Noguchi, Masaaki
Fukuoka, Shota
Kuboki, Yasutoshi
Bando, Hideaki
Okamoto, Wataru
Kojima, Takashi
Doi, Toshihiko
Ohtsu, Atsushi
Yoshino, Takayuki
机构：
[1] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan
[2] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[3] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[4] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan
[5] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[6] Natl Canc Ctr Hosp East, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.629
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
629
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [41] Management of Microsatellite Instability High (MSI-H) Gastroesophageal Adenocarcinoma
    Zhou, Katherine I.
    Hanks, Brent A.
    Strickler, John H.
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (02) : 483 - 496
  • [42] Microsatellite instability high (MSI-H) detection utilizing targeted plasma based genotyping in metastatic breast cancer
    Vidula, Neelima
    Hesler, Katherine
    Price, Kristin
    Lipman, Andrew
    Azzi, Georges
    Elkhanany, Ahmed
    Sabagh, Tarek
    Juric, Dejan
    Rodriguez, Estelamari
    Kato, Shumei
    O'Shaughnessy, Joyce
    Bardia, Aditya
    CANCER RESEARCH, 2021, 81 (04)
  • [43] The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer
    Janindra Warusavitarne
    Margaret Schnitzler
    International Journal of Colorectal Disease, 2007, 22 : 739 - 748
  • [44] Prevalence of high tumor mutational burden (TMB-H) and microsatellite instability-high (MSI-H) status in neuroendocrine neoplasms
    Padda, Sukhmani Kaur
    Aggarwal, Rahul Raj
    Ashok, Arya
    Mauer, Elizabeth
    Shirazi, Maryam
    Bergsland, Emily K.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Nivolumab ± ipilimumab treatment (Tx) efficacy, safety, and biomarkers in patients (Pts) with metastatic colorectal cancer (mCRC) with and without high microsatellite instability (MSI-H): results from the CheckMate-142 study
    Overman, M. J.
    Kopetz, S.
    Lonardi, S.
    McDermott, R.
    Leone, F.
    Leach, J.
    Lenz, H-J.
    Hendlisz, A.
    Morse, M.
    Garcia-Alfonso, P.
    Desai, J.
    Hill, A.
    Moss, R. A.
    Goldberg, M. V.
    Lin, C-S.
    Tang, H.
    Andre, T.
    ANNALS OF ONCOLOGY, 2016, 27
  • [46] Subtyping of microsatellite instability-high colorectal cancer
    Hu, Wangxiong
    Yang, Yanmei
    Qi, Lina
    Chen, Jiani
    Ge, Weiting
    Zheng, Shu
    CELL COMMUNICATION AND SIGNALING, 2019, 17 (1)
  • [47] Subtyping of microsatellite instability-high colorectal cancer
    Wangxiong Hu
    Yanmei Yang
    Lina Qi
    Jiani Chen
    Weiting Ge
    Shu Zheng
    Cell Communication and Signaling, 17
  • [48] The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer
    Warusavitarne, Janindra
    Schnitzler, Margaret
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2007, 22 (07) : 739 - 748
  • [49] COMPARISON OF REAL-WORLD LATER-LINE TREATMENT OUTCOMES IN PATIENTS WITH MICROSATELLITE-INSTABILITY HIGH (MSI-H) VERSUS MICROSATELLITE-STABLE (MSS) METASTATIC COLORECTAL CANCER (MCRC) IN THE UNITED STATES (US)
    Dixon, M.
    Gu, J.
    VALUE IN HEALTH, 2022, 25 (07) : S313 - S314
  • [50] Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the KEYNOTE-177 study Asia subgroup
    Yoshino, T.
    Andre, T.
    Kim, T. W.
    Yong, W. P.
    Shiu, K-K.
    Jensen, B. Vittrup
    Jensen, L. H.
    Punt, C. J. A.
    Smith, D.
    Garcia-Carbonero, R.
    Alcaide-Garcia, J.
    Gibbs, P.
    de la Fouchardiere, C.
    Rivera, F.
    Elez Fernandez, M. E.
    Le, D. T.
    Zuo, Y.
    Fogelman, D.
    Adelberg, D. E.
    Diaz, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S1502 - S1503
12345